Phase 2 Ovarian Cancer Recurrent Clinical Trials
6 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–6 of 6 trials
Recruiting
Phase 1Phase 2
A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer
Ovarian CancerOvarian Cancer Recurrent
Compugen Ltd60 enrolled28 locationsNCT06888921
Recruiting
Phase 1Phase 2
A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)
Ovarian Cancer Recurrent
Merck Sharp & Dohme LLC280 enrolled16 locationsNCT06843447
Recruiting
Phase 2
IN10018 in Combination With Pegylated Liposomal Doxorubicin (PLD) vs. Placebo in Combination With PLD for the Treatment of Platinum-resistant Recurrent Ovarian Cancer
Ovarian Cancer Recurrent
InxMed (Shanghai) Co., Ltd.168 enrolled1 locationNCT06014528
Recruiting
Phase 2
SBRT Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARPi Therapy
Ovarian Cancer Recurrent
Institute of Cancer Research, United Kingdom42 enrolled5 locationsNCT05990192
Recruiting
Phase 2Phase 3
Pegylated Liposomal Doxorubicin Plus Adebrelimab With or Without Mirabegron in Relapsed Ovarian Cancer
Ovarian Cancer Recurrent
Obstetrics & Gynecology Hospital of Fudan University296 enrolled1 locationNCT06791460
Recruiting
Phase 2
Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial)
Primary Peritoneal CarcinomaFallopian Tube CancerOvarian Cancer Recurrent
Shanghai Gynecologic Oncology Group167 enrolled5 locationsNCT03983226